Trial Profile
Confirmatory phase 2b study of AST-VAC1 in patients with acute myeloid leukaemia
Status:
Planning
Phase of Trial:
Phase II
Latest Information Update: 19 Nov 2016
Price :
$35
*
At a glance
- Drugs VAC 1 (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- 19 Nov 2016 New trial record
- 08 Nov 2016 According to Asterias Biotherapeutics media release, company plans to initiate this trial in 2018.